-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JmbqdVRtZC9SXNPo1+l+gZ8VmSd/X/QkCOU4pPGxaSP0AoiSxshoxk9IWiMl1Sy7 WLJEq4HBVfk4fxxCk5ohBw== 0000935069-05-002059.txt : 20050802 0000935069-05-002059.hdr.sgml : 20050802 20050802120543 ACCESSION NUMBER: 0000935069-05-002059 CONFORMED SUBMISSION TYPE: N-PX PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050630 FILED AS OF DATE: 20050802 DATE AS OF CHANGE: 20050802 EFFECTIVENESS DATE: 20050802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UBS HEALTH SCIENCES FUND LLC CENTRAL INDEX KEY: 0001116730 IRS NUMBER: 134121400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-PX SEC ACT: 1940 Act SEC FILE NUMBER: 811-09985 FILM NUMBER: 05990759 BUSINESS ADDRESS: STREET 1: 1285 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2124832323 MAIL ADDRESS: STREET 1: 1285 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: PW HEALTH SCIENCES FUND LLC DATE OF NAME CHANGE: 20000616 N-PX 1 g18481healthsciences_npx.txt UBS PAINE WEBBER HEALTH SCIENCES N-PX UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-PX ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANIES Investment Company Act file number: 811-09985 UBS HEALTH SCIENCES FUND, L.L.C. (Exact name of registrant as specified in charter) 1285 AVENUE OF THE AMERICAS, 37TH FLOOR NEW YORK, NY 10019 (Address of principal executive offices) (Zip code) JAMES J. DWYER C/O UBS FINANCIAL SERVICES, INC. 51 WEST 52ND STREET NEW YORK, NY 10019 (Name and address of agent for service) Registrant's telephone number, including area code: 212-882-5819 Date of fiscal year end: DECEMBER 31 Date of reporting period: JULY 1, 2004 - JUNE 30, 2005 Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant's proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 there under (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles. A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget ("OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507. PROXY VOTING RECORD FOR PERIOD JULY 1, 2004 TO JUNE 30, 2005 THE UBS HEALTH SCIENCES FUND, LLC DID NOT VOTE ANY PROXIES DURING THE REPORTING PERIOD. SIGNATURES Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Registrant UBS HEALTH SCIENCES FUND, L.L.C. -------------------------------- By (Signature and Title)* /S/ DOUGLAS A. LINDGREN -------------------------------------------------- Douglas Alan Lindgren, Principal Executive Officer Date: JULY 18,2005 ------------ *Print the name and title of each signing officer under his or her signature. -----END PRIVACY-ENHANCED MESSAGE-----